mRNA |
GDC-0449 |
GDSC1000 |
pan-cancer |
AAC |
0.057 |
0.1 |
mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
0.053 |
0.1 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.054 |
0.1 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.052 |
0.1 |
mRNA |
vorinostat:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.051 |
0.1 |
mRNA |
Dasatinib |
GDSC1000 |
pan-cancer |
AAC |
-0.079 |
0.1 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.053 |
0.1 |
mRNA |
AKT inhibitor VIII |
GDSC1000 |
pan-cancer |
AAC |
-0.054 |
0.1 |
mRNA |
valdecoxib |
CTRPv2 |
pan-cancer |
AAC |
0.053 |
0.1 |
mRNA |
CAY10576 |
CTRPv2 |
pan-cancer |
AAC |
0.059 |
0.1 |